MedTrace Logo

SMART: Somatotrophics, Memory, and Aging Research Trial

NCT00257712 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 151

Last updated 2013-12-19

No results posted yet for this study

Summary

The purpose of the SMART study was to better understand whether the body's own production of growth hormone (GH) would improve memory and problem solving ability, or cognitive function. The study was a double blind, placebo-controlled study of the cognitive effects of growth hormone releasing hormone (GHRH) in healthy older men and women and in those with mild cognitive impairment (MCI).

Conditions

Interventions

DRUG

TH9507 human growth hormone releasing hormone (GHRH)

1mg subcutaneous injection given daily for 20 weeks

Sponsors & Collaborators

Principal Investigators

  • Michael V. Vitiello, PhD · University of Washington

  • Suzanne Barsness, RN,MSN,CCRC · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00257712 on ClinicalTrials.gov